|

FOLFOX4 Clinical Trials

2 actively recruiting trials

Pipeline

Phase 1: 1

Top Sponsors

  • Nanjing Tianyinshan Hospital1
  • Gustave Roussy, Cancer Campus, Grand Paris1

Indications

  • Cancer2
  • Liver Disease1
  • Locally Advanced Rectal Cancer1
  • Hepatocellular Carcinoma (HCC)1
  • Liver Cancer1

Other2 trials

Individualized Comprehensive Treatment for Advanced Hepatocellular Carcinoma
N/A
Preoperative Radiotherapy And ASTX660 in Rectum Cancer
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.